A Systematic Review of Value-Based Insurance Design in Chronic Diseases
October 14th 2014Value-based insurance design for prescription drug coverage increases drug adherence in patients with chronic disease, though their effect on clinical outcomes and health spending remain uncertain.
Novel Predictive Models for Metabolic Syndrome Risk: A "Big Data" Analytic Approach
June 26th 2014The authors evaluated a new "big data" analytic predictive platform that quickly and accurately analyzes large data sets to identify populations at risk of developing conditions such as metabolic syndrome.
Comparison Between Guideline-Preferred and Nonpreferred First-Line HIV Antiretroviral Therapy
June 19th 2014Initiation of guideline-preferred first-line antiretroviral therapy (ART) was associated with better ART adherence and persistence and similar total healthcare expenditures among Medicaid-insured HIV patients.
The Value of Specialty Pharmaceuticals - A Systematic Review
June 19th 2014This study examines whether patients treated with specialty pharmaceuticals have improved outcomes compared with patients treated with conventional therapies, and evaluates costs associated with these treatments.